Biomarkers & Translational Bioanalysis

Biomarkers become powerful when they are connected to a biological question and a development decision. Whether the objective is to demonstrate target engagement, measure pharmacodynamic response, characterize immune activation, or understand treatment-related changes, Boveevo selects the analytical platform around the biology and the sample—not the other way around. We bring together flow cytometry, multiplex protein analysis, imaging, and molecular techniques to generate quantitative biomarker data from preclinical and, through appropriate specialist capabilities, clinical samples. A key area of our expertise is low-volume biomarker analysis, using multiplex platforms such as Luminex with sample volumes as low as 10 µL, helping maximize data generation when sample availability is limited. We also offer CBA-based approaches as a cost-effective solution for targeted cytokine and protein biomarker profiling. This integrated, sample-efficient approach helps bridge efficacy studies with translational endpoints and creates a clearer path from experimental signal to meaningful evidence.

Technology Platforms

✔️ Flow cytometry

✔️ High-parameter immune phenotyping

✔️ Intracellular cytokine staining

✔️ Phospho-flow

✔️ Luminex

✔️ Cytometric Bead Array (CBA)

✔️ ELISA

✔️ Incucyte / live-cell imaging

✔️ Western blot / Simple Western

✔️ RT-qPCR

✔️ ddPCR

✔️ ELISpot / FluoroSpot

✔️ Cell-based functional biomarkers

✔️ Histology / IHC / IF through specialist partners